Testing effectiveness (Phase 2)Study completedNCT02517099What this trial is testingPreschool Wheeze: Inflammation/Infection Guided ManagementWho this might be right forAsthma Imperial College London 60
Testing effectiveness (Phase 2)Study completedNCT01490632What this trial is testingA Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisWho this might be right forPsoriasisSkin DiseasesSkin Diseases, Papulosquamous Eli Lilly and Company 271
Large-scale testing (Phase 3)Study completedNCT00554164What this trial is testingPositron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's LymphomasWho this might be right forLymphoma, High-grade University Hospital, Essen 1,073
Early research (Phase 1)Study completedNCT02323880What this trial is testingSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasWho this might be right forMalignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more Children's Oncology Group 59
Testing effectiveness (Phase 2)Study completedNCT00885196What this trial is testingA Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque PsoriasisWho this might be right forModerate and Severe Plaque Psoriasis Novartis Pharmaceuticals 336
Not applicableStudy completedNCT06004167What this trial is testingAdaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)Who this might be right forLymphoma, B-CellRelapsed CancerRefractory Lymphoma+5 more Massachusetts General Hospital 10
Testing effectiveness (Phase 2)UnknownNCT04914741What this trial is testingA Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma Peter MacCallum Cancer Centre, Australia 80
Early research (Phase 1)Not Yet RecruitingNCT07714421What this trial is testingEpcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit PatientsWho this might be right forDiffuse Large B-Cell LymphomaGrade 3b Follicular LymphomaHigh Grade B-Cell Lymphoma+2 more Jonsson Comprehensive Cancer Center 20
Not applicableUnknownNCT02373839What this trial is testingRole of Placental Growth Factor (PlGF) in the Management of Non-Severe PreeclampsiaWho this might be right forPregnancy; Pre-eclampsia, Mild Fetal Medicine Research Center, Spain 300
Testing effectiveness (Phase 2)Looking for participantsNCT05256641What this trial is testingAcalabrutinib Maintenance for the Treatment of Patients With Large B-cell LymphomaWho this might be right forDiffuse Large B-Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma+1 more Jonsson Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00138086What this trial is testingYttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell LymphomaWho this might be right forB-Cell Lymphoma Lymphoma Study Association 75
Not applicableStudy completedNCT00695422What this trial is testingDetecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical TrialsWho this might be right forAids-related MalignanciesLymphomaPrecancerous Condition+1 more AIDS Malignancy Consortium 47
Not applicableLooking for participantsNCT01351545What this trial is testingAccess and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)Who this might be right forHematologic MalignanciesInherited Disorders of MetabolismInherited Abnormalities of Platelets+14 more Center for International Blood and Marrow Transplant Research 99,999
Testing effectiveness (Phase 2)WithdrawnNCT00004039What this trial is testingCombination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV LymphomaWho this might be right forLymphoma Hoag Memorial Hospital Presbyterian
Early research (Phase 1)Ended earlyNCT05660395What this trial is testingEvaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)Who this might be right forDiffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma ADC Therapeutics S.A. 5
Early research (Phase 1)Study completedNCT00004212What this trial is testingDX-8951f in Treating Children With Advanced Solid Tumors or LymphomasWho this might be right forBrain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific Daiichi Sankyo
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07814001What this trial is testingEpcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell TherapyWho this might be right forRefractory Diffuse Large B-Cell Lymphoma (DLBCL)Refractory Large B-cell Lymphoma (LBCL)Refractory T-cell/Histiocyte-rich Large B-cell Lymphoma+3 more The Lymphoma Academic Research Organisation 55
Testing effectiveness (Phase 2)Looking for participantsNCT06905509What this trial is testingEpcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements+11 more University of California, Davis
Large-scale testing (Phase 3)Study completedNCT01305577What this trial is testingEvaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental FatWho this might be right forModerate or Severe Submental Fullness Kythera Biopharmaceuticals 363
Testing effectiveness (Phase 2)Study completedNCT00785330What this trial is testingAllo-hNHL (FluBuCy)Who this might be right forNon-Hodgkin's Lymphoma Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 84